A Bayesian Group Sequential Approach for Multiple Endpoints
From MaRDI portal
Publication:4678861
DOI10.1081/SQA-200046829zbMath1061.62118MaRDI QIDQ4678861
Stewart J. Anderson, Maria K. Mor
Publication date: 23 May 2005
Published in: Sequential Analysis (Search for Journal in Brave)
Multivariate analysis (62H99) Applications of statistics to biology and medical sciences; meta analysis (62P10) Bayesian inference (62F15) Bayesian problems; characterization of Bayes procedures (62C10) Sequential statistical design (62L05)
Cites Work
- Unnamed Item
- Monitoring Accumulating Data in a Clinical Trial
- One-Sided Sequential Stopping Boundaries for Clinical Trials: A Decision- Theoretic Approach
- Testing Hypotheses About an Identified Treatment When There are Multiple Endpoints
- Group Sequential Tests for Bivariate Response: Interim Analyses of Clinical Trials with Both Efficacy and Safety Endpoints
- Designs for Phase II Trials Allowing for a Trade-Off between Response and Toxicity
- Incorporating Toxicity Considerations Into the Design of Two-Stage Phase II Clinical Trials
- Approaches for Optimal Sequential Decision Analysis in Clinical Trials
- Bayesian Design and Analysis of Active Control Clinical Trials
- Approximate Bayesian Evaluation of Multiple Treatment Effects
- Bayesian Approaches to Randomized Trials
- Bivariate Sequential Designs for Phase II Trials
- On The Design and Analysis of Randomized Clinical Trials with Multiple Endpoints
This page was built for publication: A Bayesian Group Sequential Approach for Multiple Endpoints
